Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director
Quarterly results

Arch Therapeutics, Inc. (ARTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/27/2023 SC 13G/A Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc.
01/25/2023 SC 13G/A Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc.
01/12/2022 SC 13G/A Parker Michael Andrew reports a 8.8% stake in Arch Therapeutics, Inc.
01/22/2021 SC 13G/A Parker Michael Andrew reports a 8% stake in Arch Therapeutics, Inc.
01/23/2020 SC 13G/A Parker Michael Andrew reports a 7.6% stake in Arch Therapeutics, Inc.
02/11/2019 SC 13G/A Parker Michael Andrew reports a 5.8% stake in Arch Therapeutics, Inc.
02/06/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2017 SC 13G/A Parker Michael Andrew reports a 7.2% stake in Arch Therapeutics, Inc.
03/15/2016 SC 13G/A Parker Michael Andrew reports a 5.9% stake in Arch Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy